Search Results 7031-7040 of 34714 for oral

1. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

   Previous experience with an oral or injectable GLP-1 agonist;; Use of the following within 2 weeks of screening: an other GLP-1 agonist, an NK-1 antagonist ...

2. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Oral and throat cancer, Salivary gland cancer, Thyroid cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Salivary gland tumor, Laryngeal cancer ...

3. Neurology - Doctors - Mayo Clinic

   oral lobe seizure, Seizure , Absence seizure, Febrile seizure. Show more areas of focus for Anthony L. Fine, M.D.. Sanford M. Fineman ...

4. Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) - Mayo Clinic

   - Chronic use of oral steroid medications, ketoconazole (except for topical formulations), St. John's Wort, or other IPs is not permitted - Have an active ...

5. A Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines - Mayo Clinic

   Participation eligibility · Concomitant medical condition that will require oral or injectable steroids during the study. · Currently on a stable regime of more ...

6. A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps. - Mayo Clinic

   ... oral or esophageal lesions/ulcers; Presence of laryngospasm or significant swallowing problems; Presence of percutaneous endoscopic gastrostomy ...

7. A Study to Evaluate Dapagliflozin to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure - Mayo Clinic

   ... oral steroid therapy, or hospitalisation for exacerbation of COPD requiring ventilatory assist within 12 months prior to enrolment). Previous cardiac ...

8. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

   Treatment with oral or parenteral corticosteroids dosed greater than 40 mg hydrocortisone daily or its equivalent (e.g., prednisone 10 mg, prednisolone 8 mg ...

9. A Study to Investigate the Safety and Effectiveness of FE 999049 in Controlled Ovarian Stimulation in Women Aged 35-42 Years Old - Mayo Clinic

   ... oral contraceptives, progestogen or estrogen preparations. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

10. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    Received treatment of infection with intravenous (within 30 days of baseline) or oral (within 14 days prior to baseline) antibiotics, antivirals, or antifungals ...